ClinicalTrials.Veeva

Menu

Performance Proof of the New NORMA-SENSE

I

Israel Healthcare Foundation

Status

Unknown

Conditions

Vaginal Infection

Treatments

Device: NORMA-SENSE

Study type

Observational

Funder types

Other

Identifiers

NCT00802763
F-7-28.1-1 VER-2

Details and patient eligibility

About

This study was designed to validate the color appearance on the newly developed panty liner (NORMA-SENSE). The NORMA-SENSE liner changes color when worn by the user and comes into contact with vaginal secretion with an elevated pH level, without false positives due to urine remains or incontinence. The study will also asses the physical comfort in using NORMA-SENSE and the result reading clarity which includes the ability to visualize and interpret the NORMA-SENSE strip results.

Enrollment

224 estimated patients

Sex

Female

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Women, age 18 years or greater without symptoms of vaginal infection.
  2. Subject is ready to sign the informed consent form.

Exclusion criteria

  1. Subject is unable or unwilling to cooperate with study procedures.
  2. Subject is currently participating in another clinical study.
  3. Subject suffers from vaginal bleeding or is menstruating.
  4. Subject that have had sexual relations within the last 12 hours.
  5. Subject that applied local antiseptic or antibiotic or vaginal treatment within the last 3 days.
  6. Subject that applied vaginal douching within 12 hours prior to the visit at the clinic.

Trial design

224 participants in 1 patient group

vaginitis
Treatment:
Device: NORMA-SENSE

Trial contacts and locations

1

Loading...

Central trial contact

HADAR KESSARY, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems